- Home
- TARA vs RDCM Comparison
TARA vs RDCM Comparison
Compare TARA & RDCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TARA | RDCM |
|---|---|---|
| Founded | N/A | 1985 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 236.1M | 270.2M |
| IPO Year | 2014 | 1999 |
Fundamental Metrics
Financial Performance| Metric | TARA | RDCM |
|---|---|---|
| Price | $3.92 | $10.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $24.40 | $18.00 |
| AVG Volume (30 Days) | ★ 481.8K | 142.8K |
| Earning Date | 05-01-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.25 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,948,000.00 | N/A |
| Revenue This Year | N/A | $11.50 |
| Revenue Next Year | N/A | $9.74 |
| P/E Ratio | ★ N/A | $16.35 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.97 | $9.40 |
| 52 Week High | $7.82 | $16.74 |
Technical Indicators
Market Signals| Indicator | TARA | RDCM |
|---|---|---|
| Relative Strength Index (RSI) | 41.88 | 22.36 |
| Support Level | $3.69 | N/A |
| Resistance Level | $4.23 | $13.27 |
| Average True Range (ATR) | 0.17 | 0.52 |
| MACD | -0.01 | -0.37 |
| Stochastic Oscillator | 19.09 | 15.01 |
Price Performance
Historical ComparisonAbout TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.
About RDCM Radcom Ltd.
Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.